Theratechnologies inc.
TSX : TH

Theratechnologies inc.

January 13, 2006 15:24 ET

Theratechnologies Notes Passing of Board Member Andre Delambre

MONTREAL, QUEBEC--(CCNMatthews - Jan. 13, 2006) - Theratechnologies (TSX:TH) today announced with sadness the passing of Mr. Andre Delambre, a valued member of its Board of Directors. Mr. Delambre passed away on January 9, 2006 after a courageous battle with amyotrophic lateral sclerosis (Lou Gehrig's disease).

A member of Theratechnologies' Board since 2000, Andre Delambre was Executive Vice President of Les Productions Feeling Inc., managing the affairs of popular recording artist Celine Dion. Prior to that, he was partner with the accounting firm Samson, Belair, Deloitte & Touche. Mr. Delambre was also actively involved in various foundations as Director and canvasser and created the Fondation Andre Delambre in 2003, dedicated to helping people suffering from amyotrophic lateral sclerosis.

Mr. A. Jean de Grandpre, Chairman of the Board of Directors commented: "Andre Delambre was a strong contributor to our Board and a very active member of the Audit Committee. An attentive listener and clear thinker, one of Andre's greatest strengths was a remarkable ability to distill issues down to what is important and offer practical solutions to difficult problems. In recent years, we were all full of admiration for the way that he confronted his terrible disease with unfailing courage and amazing generosity of spirit. To the very end, Andre was a strong believer in Theratechnologies and he will be greatly missed by his many friends in the Company."

About Theratechnologies

Theratechnologies (TSX: TH) is a Canadian biopharmaceutical company that discovers or acquires innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets where it can retain full or partial commercial rights for its products. Its most advanced program is TH9507, now in Phase 3 clinical trials for a serious metabolic syndrome known as HIV-associated lipodystrophy. The Company also has other promising projects at earlier stages of development.

Additional information about Theratechnologies

Further information relating to Theratechnologies is available on the Company's website at http://www.theratech.com/. The Company is listed on the Toronto Stock Exchange under the symbol TH. Additional information, including the Company's Annual Information Form, is available on SEDAR at www.sedar.com.


Contact Information